引用本文:吴德升.椎间盘退变干细胞生物学修复的临床研究进展与挑战[J].中国临床新医学,2023,16(3):201-206.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1247次   下载 1069 本文二维码信息
码上扫一扫!
分享到: 微信 更多
椎间盘退变干细胞生物学修复的临床研究进展与挑战
吴德升
200120 上海,同济大学附属东方医院脊柱外科
摘要:
[摘要] 椎间盘退变(IDD)是多数脊柱退变性疾病共同的病理基础,是下腰痛最主要的致病因素。以间充质干细胞(MSCs)为基础的生物学修复为IDD的治疗提供了新思路。近年来临床应用MSCs治疗IDD取得了良好的疗效。该文就IDD干细胞生物学修复的临床研究现状、所面临的问题和挑战及潜在的突破点进行述评,为IDD干细胞生物学修复的临床研究提供参考。
关键词:  椎间盘退变  间充质干细胞  生物学修复  述评
DOI:10.3969/j.issn.1674-3806.2023.03.01
分类号:R 681.5
基金项目:国家自然科学基金面上项目(编号:82272537,81972106)
Biological repair of stem cells for intervertebral disc degeneration:clinical research progress and challenges
WU De-sheng
Department of Spine Surgery, Shanghai East Hospital, Tongji University, Shanghai 200120, China
Abstract:
[Abstract] Intervertebral disc degeneration(IDD) is considered as the common pathological basis of most spinal degenerative diseases and is a major pathogenic factor of low back pain. Mesenchymal stem cells(MSCs)-based biological repair provides a new idea for the treatment of IDD. In recent years, the clinical application of MSCs in the treatment of IDD has achieved good results in some extent. In this paper, the current status, problems, challenges and potential breakthrough points of the clinical research on biological repair of stem cells for IDD are reviewed, providing reference for the clinical research on biological repair of stem cells for IDD.
Key words:  Intervertebral disc degeneration(IDD)  Mesenchymal stem cells(MSCs)  Biological repair  Review